| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 287-293, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
JC Ramirez, GA Patterson, TL Winton, AL de Hoyos, JD Miller and JR Maurer
Between March 1988 and March 1991, 17 patients underwent bilateral lung
transplantation for end-stage lung disease caused by cystic fibrosis. There
were 11 male and six female patients. Ages ranged from 19 to 41 years (mean
age 28 years). Preoperative mean arterial oxygen tension with the patient
breathing room air was 54 +/- 6 mm Hg; forced vital capacity, 1.8 +/- 0.7
L; forced expiratory volume in 1 second, 0.9 +/- 0.3 L; and 6-minute walk
test, 506 +/- 44 m. Immunosuppression consisted of cyclosporine,
azathioprine, and prednisone. Induction immunosuppression was obtained with
Minnesota antilymphocyte globulin. All patients received perioperative
antibiotics according to sputum cultures and sensitivities. There were six
operative deaths, four of which resulted from bacterial infection. Two
patients required a second transplantation, one receiving a single lung and
one undergoing bilateral lung replacement. Significant functional
improvement was observed in all survivors. At 3 months follow-up, mean
arterial oxygen tension on room air was 95 +/- 6 mm Hg (p less than 0.01);
forced vital capacity, 3 +/- 0.8 L (p less than 0.01); forced expiratory
volume in 1 second, 2.6 +/- 0.9 L (p less than 0.01); and 6-minute walk
test, 678 +/- 47 m (p less than 0.01). The actuarial survival rate was 66%
at 3 months and 58% at 6, 12, and 24 months. The most frequent cause of
morbidity and mortality was acute pneumonia resulting from Pseudomonas
cepacia. For patients with respiratory failure caused by cystic fibrosis,
bilateral lung transplantation is an effective treatment option associated
with significant functional improvement.
ARTICLES
Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group
Department of Surgery, University of Toronto, Ontario, Canada.
This article has been cited by other articles:
|
|
 |
|
  T. G. Liou, F. R. Adler, and D. Huang Use of Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 1053 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.M. Egan, F.C. Detterbeck, M.R. Mill, M.S. Bleiweis, R. Aris, L. Paradowski, G. Retsch-Bogart, and B.S. Mueller Long term results of lung transplantation for cystic fibrosis Eur. J. Cardiothorac. Surg., October 1, 2002; 22(4): 602 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Liou, F. R. Adler, B. C. Cahill, S. C. FitzSimmons, D. Huang, J. R. Hibbs, and B. C. Marshall Survival Effect of Lung Transplantation Among Patients With Cystic Fibrosis JAMA, December 5, 2001; 286(21): 2683 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.M. Jones, M.E. Dodd, and A.K. Webb Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas Eur. Respir. J., February 1, 2001; 17(2): 295 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. CHAPARRO, J. MAURER, C. GUTIERREZ, M. KRAJDEN, C. CHAN, T. WINTON, S. KESHAVJEE, M. SCAVUZZO, E. TULLIS, M. HUTCHEON, et al. Infection with Burkholderia cepacia in Cystic Fibrosis . Outcome Following Lung Transplantation Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 43 - 48. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. W. Barlow, R. C. Robbins, M. R. Moon, O. Akindipe, J. Theodore, and B. A. Reitz HEART-LUNG VERSUS DOUBLE-LUNG TRANSPLANTATION FOR SUPPURATIVE LUNG DISEASE J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 466 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wiebe, Th. Wahlers, W. Harringer, H.v.d. Hardt, H. Fabel, and A. Haverich Lung transplantation for cystic fibrosis - a single center experience over 8 years Eur. J. Cardiothorac. Surg., August 1, 1999; 14(2): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Doershuk and R. C. Stern Timing of Referral for Lung Transplantation for Cystic Fibrosis: Overemphasis on FEV1 May Adversely Affect Overall Survival Chest, March 1, 1999; 115(3): 782 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Caronia, J. Gorvoy, P. Silver, C. Quinn, L. Nimkoff, and M. Sagy Use of Bilevel Positive Airway Pressure (BIPAP) in End-Stage Patients with Cystic Fibrosis Awaiting Lung Transplantation Clinical Pediatrics, September 1, 1998; 37(9): 555 - 559. [Abstract] [PDF]
|
|
|
|
 |
|
 T. M. Egan, F. C. Detterbeck, M. R. Mill, K. K. Gott, J. B. Rea, J. McSweeney, R. M. Aris, and L. J. Paradowski Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk group Ann. Thorac. Surg., August 1, 1998; 66(2): 337 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. Mendeloff, C. B. Huddleston, G. B. Mallory, E. P. Trulock, A. H. Cohen, S. C. Sweet, J. Lynch, S. Sundaresan, J. D. Cooper, and G. A. Patterson Pediatric And Adult Lung Transplantation For Cystic Fibrosis J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 404 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Couetil, D. P. Houssin, O. Soubrane, P. G. Chevalier, B. E. Dousset, D. Loulmet, A. Achkar, M. J. Tolan, C. I. Amrein, A. Guinvarch, et al. COMBINED LUNG AND LIVER TRANSPLANTATION IN PATIENTS WITH CYSTIC FIBROSIS: A 4 1/2-year experience J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1415 - 1423. [Abstract] [Full Text]
|
|
|
|
|
|
M. S. Herridge, A. L. de Hoyos, C. Chaparro, T. L. Winton, S. Kesten, and J. R. Maurer Pleural complications in lung transplant recipients J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 22 - 26. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. A. Fulton, D. M. Orenstein, A. N. Koehler, and G. Kurland Nutrition in the Pediatric Double Lung Transplant Patient With Cystic Fibrosis Nutr Clin Pract, April 1, 1995; 10(2): 67 - 72. [Abstract] [PDF]
|
|
|
|
|
|
H. Date, S. Izumi, Y. Miyade, A. Andou, N. Shimizu, and S. Teramoto Successful Canine Bilateral Single-Lung Transplantation After 21-Hour Lung Preservation Ann. Thorac. Surg., February 1, 1995; 59(2): 336 - 341. [Abstract] [Full Text]
|
|
|
|
|
|
T. M. Egan, F. C. Detterbeck, M. R. Mill, L. J. Paradowski, R. P. Lackner, W. D. Ogden, J. R. Yankaskas, J. H. Westerman, J. T. Thompson, M. A. Weiner, et al. Improved results of lung transplantation for patients with cystic fibrosis J. Thorac. Cardiovasc. Surg., February 1, 1995; 109(2): 224 - 235. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Steinbach, L. Sun, R.-Z. Jiang, P. Flume, P. Gilligan, T. M. Egan, and R. Goldstein Transmissibility of Pseudomonas cepacia Infection in Clinic Patients and Lung-Transplant Recipients with Cystic Fibrosis N. Engl. J. Med., October 13, 1994; 331(15): 981 - 987. [Abstract] [Full Text]
|
|
|
|
|
|
S. E. Weinberger Recent Advances in Pulmonary Medicine- Second of Two Parts N. Engl. J. Med., May 20, 1993; 328(20): 1462 - 1470. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
